Fellowship · Orange, CA
Sponsored by University of California (Irvine)
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Journal of hepatology · 2023 · 2,696 citations · Timothy Morgan
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology (Baltimore, Md.) · 2023 · 2,397 citations · Timothy Morgan
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Annals of hepatology · 2024 · 542 citations · Timothy Morgan
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance.
Hepatology (Baltimore, Md.) · 2025 · 157 citations · Timothy Morgan
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
Journal of hepatology · 2025 · 148 citations · Timothy Morgan
Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.
Hepatology (Baltimore, Md.) · 2026 · 51 citations · Timothy Morgan
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment.
Current diabetes reports · 2023 · 179 citations · Kishore Gadde
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study.
Diabetes care · 2021 · 263 citations · Kishore Gadde